Gregory Potts is a Principal Research Scientist at AbbVie, specializing in peptide and protein identification through advanced techniques such as LC/MS/MS method development and data visualization, contributing to the discovery of novel immuno-oncology targets. Previously, Gregory served as Research Scientist III at Thermo Fisher Scientific, focusing on deep proteome analysis and mass spectrometry for antibody characterization, alongside roles in bioinformatics and standard operating procedure development. Gregory began an academic career as an Analytical Chemist and Mass Spectrometrist at the University of Wisconsin-Madison, where research concentrated on proteomes and post-translational modifications. Education includes a PhD in Analytical Chemistry from the University of Wisconsin-Madison and a Bachelor's degree in Chemistry from the University of Illinois Urbana-Champaign.
July, 2024 - present
July, 2021
March, 2017